Q3 2025 Imerys SA Earnings Call Transcript

Oct 30, 2025 / 05:00PM GMT

Release Date Price: $34.01

Transcript

Key Points

Positve

Imerys (IMYSY) maintained a resilient EBITDA of EUR421 million for the first 9 months, demonstrating stability despite challenging market conditions.
The company confirmed its full-year 2025 adjusted EBITDA target in the range of EUR540 million to EUR580 million.
Imerys (IMYSY) signed an agreement to acquire SB Mineracao in Brazil, strengthening its footprint in the region.
The company entered into strategic partnerships to enhance its product portfolio for batteries, addressing Europe's need for a competitive battery supply chain.
Imerys (IMYSY) signed a 10-year corporate purchase agreement for renewable electricity, significantly reducing its CO2 emissions by 14% of Scope 2 emissions.

Negative

Revenue for the first 9 months was slightly down by 0.7% like-for-like compared to last year, indicating a challenging market environment.
The US market experienced an unexpected slowdown in Q3, impacting Imerys (IMYSY)'s performance due to tariffs and weak residential markets.
The company faced a 21% decrease in adjusted EBITDA compared to last year, affected by lower joint venture contributions and unfavorable exchange rates.
Imerys (IMYSY) is launching a comprehensive cost reduction program due to delayed market recovery, indicating ongoing financial pressures.
The Graphite & Carbon segment experienced a slowdown in growth, attributed to operational disruptions and a high comparison base.

Operator

Good day, and thank you for standing by. Welcome to the Imerys 2025 first 9-months and third quarter results conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speakers today, Alessandro Dazza, Chief Executive Officer; and Sebastien Rouge, Chief Financial Officer. Please go ahead.

Alessandro Dazza

Imerys SA - Chief Executive Officer, Member of the Executive Committee

Thank you. Good afternoon or good evening to all of you, and thank you for joining us today to review Imerys first 9-months and Q3 2025 results. Next to me this evening, as usual, Sebastien Rouge, our CFO. And as usual, please let me start by giving you some highlights for the 9-months we just closed.

Imerys performance for the 9-months is the result of a positive start to the year and a softer second part. Q3 reflected in honestly, unexpected slowdown in the US economy as a result of uncertainty caused by the US tariffs policy. Europe, even if overall activity remains low,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.